Hebei Weimiao Biology Co., LTD 1
Location
  • Home
  • Hydroxychloroquine Sulfate CAS 747-36-4 Usage and Research Developments in China

Nov . 23, 2024 23:53 Back to list

Hydroxychloroquine Sulfate CAS 747-36-4 Usage and Research Developments in China



Hydroxychloroquine Sulfate A Closer Look at CAS 747-36-4


Hydroxychloroquine sulfate, commonly referred to by its chemical abstract service (CAS) number 747-36-4, is a pharmaceutical compound that has garnered considerable attention in recent years. Initially developed as an antimalarial drug, hydroxychloroquine is also used in the treatment of autoimmune conditions such as rheumatoid arthritis and systemic lupus erythematosus. Its mechanism of action, therapeutic applications, and the spotlight it found during the COVID-19 pandemic make it an interesting subject of discussion.


History and Development


Hydroxychloroquine sulfate was first synthesized in the 1940s, deriving from chloroquine, a drug that has been in use since World War II to prevent and treat malaria. As research progressed, it became apparent that hydroxychloroquine also exhibited immunomodulatory effects, which led to its approval for various autoimmune diseases. The drug is categorized under the class of antimalarials and has a well-established safety profile, making it a preferred choice for long-term treatment of certain chronic diseases.


Mechanism of Action


Hydroxychloroquine works through multiple mechanisms. It acts primarily as an immunosuppressant, inhibiting the activity of immune cells and the production of pro-inflammatory cytokines. This makes it effective in reducing the symptoms associated with autoimmune diseases, where the immune system erroneously attacks healthy tissues. Additionally, hydroxychloroquine interferes with the communication pathways of immune cells, contributing to its ability to provide relief in diseases like lupus and rheumatoid arthritis.


Furthermore, hydroxychloroquine has shown activity in altering the pH within cellular compartments, which may play a crucial role in preventing the replication of certain viruses

. This property was particularly investigated during the COVID-19 pandemic when hydroxychloroquine was proposed as a potential treatment option for the novel coronavirus.
china hydroxychloroquine sulfate cas747-36-4

Hydroxychloroquine Sulfate CAS 747-36-4 Usage and Research Developments in China

Hydroxychloroquine and COVID-19


The COVID-19 pandemic catalyzed a massive surge in interest surrounding hydroxychloroquine sulfate. Early in the pandemic, the drug was heralded by some as a possible cure for COVID-19, with various small studies suggesting potential benefits. However, subsequent larger-scale clinical trials yielded conflicting results, leading to widespread debate and controversy within the scientific community and the public. Regulatory agencies, including the U.S. Food and Drug Administration (FDA), ultimately issued warnings against its use for COVID-19 outside of clinical trials due to safety concerns and lack of evidence for efficacy.


Despite the initial excitement, the consensus gradually shifted towards recognizing that hydroxychloroquine is not a viable treatment for COVID-19. This has reinforced the importance of rigorous scientific testing and evidence-based medicine, underscoring the need for caution when considering unproven treatments during health crises.


Current and Future Applications


Outside the realm of infectious diseases, hydroxychloroquine sulfate continues to be widely used in managing autoimmune diseases. Ongoing research is exploring its potential benefits in other conditions, including certain dermatological disorders, pregnancy-related complications, and as an adjunctive therapy in cancer treatment. As we progress, understanding its full therapeutic potential and identifying any novel applications through rigorous scientific inquiry remains crucial.


Conclusion


In summary, hydroxychloroquine sulfate (CAS 747-36-4) serves as a notable example of a drug with a rich history and multifaceted applications. While its role in treating malaria and autoimmune diseases is well-documented, the lessons learned during the COVID-19 pandemic highlight the need for critical assessment of drug efficacy and safety. As research continues, hydroxychloroquine may still reveal new insights and applications in medicine, but careful consideration of data and regulation will play a vital role in ensuring patient safety and advancing therapeutic strategies.


Share
Next：

Latest news

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Hit enter to search or ESC to close
en_USEnglish
afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati htHaitian Creole haHausa hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu en_USEnglish